We are very grateful to The James Tudor Foundation for awarding £120,000 to the TSA to assist with funding of the Rapamycin trials.

This is great news which brings with it a lot of hope for all those affected by Tuberous Sclerosis.

This entry was posted on Wednesday, July 26th, 2006 at 2:10 pm and is filed under Fundraising.